Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
WZ4002
Cat No.
CEI-0014
Description
As a novel, mutant-selective EGFR inhibitor, WZ4002 is can inhibit EGFR(L858R) and EGFR(L858R/T790M) with IC50 of 2 nM and 8 nM.
CAS No.
1213269-23-8
Molecular Weight
494.18
Purity
>99%
Storage
2 years at -20 centigrade
Targets
EGFR(L858R), EGFR(L858R/T790M)
Molecular Formula
C25H27ClN6O3
Chemical Name
N-(3-(5-chloro-2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-yloxy)phenyl)acrylamide
Solubility
DSMO 13 mg/mL Water
In vitro
As a novel, mutant-selective EGFR inhibitor, WZ4002 is can inhibit EGFR(L858R) and EGFR(L858R/T790M) with IC50 of 2 nM and 8 nM..WZ4002 can inhibit widetype ERBB2 with an IC50 of 32 nM. WZ4002 inhibits EGFR, AKT and ERK1/2 phosphorylation in NSCLC cell lines.WZ4002 prevents EGFR kinase activity of recombinant L858R/T790M protein more potently than of WT EGFR, while the opposite is observed with HKI-272 and gefitinib.
In vivo
WZ4002 treatment results in significant tumor regressions compared to vehicle alone in both T790M containing murine models.
Download
Download Datasheet